[
  {
    "ts": null,
    "headline": "Will Declining Gardasil Sales Ail MRK's Top Line in Q3 Earnings?",
    "summary": "Merck faces a sharp Gardasil slowdown as weak demand in China and Japan affects sales of the vaccine.",
    "url": "https://finnhub.io/api/news?id=ff06e0b8d8169c5d7baca519b461f324a1aa4ffd941cd2b29a292149e16fc0d4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760718000,
      "headline": "Will Declining Gardasil Sales Ail MRK's Top Line in Q3 Earnings?",
      "id": 137127561,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Merck faces a sharp Gardasil slowdown as weak demand in China and Japan affects sales of the vaccine.",
      "url": "https://finnhub.io/api/news?id=ff06e0b8d8169c5d7baca519b461f324a1aa4ffd941cd2b29a292149e16fc0d4"
    }
  },
  {
    "ts": null,
    "headline": "Bank of America Securities Reduces PT on Merck & Co., Inc. (MRK), Keeps a Buy Rating",
    "summary": "​Merck & Co., Inc. (NYSE:MRK) is one of the Best Forever Stocks to Invest In Now. On October 10, Tim Anderson of Bank of America Securities reduced the firm’s price target on Merck & Co., Inc. (NYSE:MRK) from $99 to $98, while keeping a Buy rating on the stock. ​The firm sees the company as […]",
    "url": "https://finnhub.io/api/news?id=36d69fda78d7aa4e18a70c8569a6d02953cd0a0fd8c3dac5f48224e8cdd5601b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760713749,
      "headline": "Bank of America Securities Reduces PT on Merck & Co., Inc. (MRK), Keeps a Buy Rating",
      "id": 137125779,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "​Merck & Co., Inc. (NYSE:MRK) is one of the Best Forever Stocks to Invest In Now. On October 10, Tim Anderson of Bank of America Securities reduced the firm’s price target on Merck & Co., Inc. (NYSE:MRK) from $99 to $98, while keeping a Buy rating on the stock. ​The firm sees the company as […]",
      "url": "https://finnhub.io/api/news?id=36d69fda78d7aa4e18a70c8569a6d02953cd0a0fd8c3dac5f48224e8cdd5601b"
    }
  },
  {
    "ts": null,
    "headline": "Trump Strikes Deal With German Merck on Tariffs and IVF Costs",
    "summary": "The administration will be issuing guidance to allow employers to offer fertility perks as excepted benefits, a category that includes supplemental health coverage like dental and vision.  The guidance will allow employers to offer add-on coverage at a fixed cost for patients and employers.  The White House previously issued an executive order directing the administration to produce by May policy recommendations aimed at lowering the cost of expensive fertility treatments.",
    "url": "https://finnhub.io/api/news?id=c8bb74ce1bfa6c61a4da872f73b71ff556ba0806602adbddc7aa0830b2610764",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760645193,
      "headline": "Trump Strikes Deal With German Merck on Tariffs and IVF Costs",
      "id": 137109689,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "The administration will be issuing guidance to allow employers to offer fertility perks as excepted benefits, a category that includes supplemental health coverage like dental and vision.  The guidance will allow employers to offer add-on coverage at a fixed cost for patients and employers.  The White House previously issued an executive order directing the administration to produce by May policy recommendations aimed at lowering the cost of expensive fertility treatments.",
      "url": "https://finnhub.io/api/news?id=c8bb74ce1bfa6c61a4da872f73b71ff556ba0806602adbddc7aa0830b2610764"
    }
  }
]